Natural selection at the RASGEF1C (GGC) repeat in human and divergent genotypes in late-onset neurocognitive disorder.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
28 09 2021
Historique:
received: 29 08 2021
accepted: 14 09 2021
entrez: 29 9 2021
pubmed: 30 9 2021
medline: 29 12 2021
Statut: epublish

Résumé

Expression dysregulation of the neuron-specific gene, RASGEF1C (RasGEF Domain Family Member 1C), occurs in late-onset neurocognitive disorders (NCDs), such as Alzheimer's disease. This gene contains a (GGC)13, spanning its core promoter and 5' untranslated region (RASGEF1C-201 ENST00000361132.9). Here we sequenced the (GGC)-repeat in a sample of human subjects (N = 269), consisting of late-onset NCDs (N = 115) and controls (N = 154). We also studied the status of this STR across various primate and non-primate species based on Ensembl 103. The 6-repeat allele was the predominant allele in the controls (frequency = 0.85) and NCD patients (frequency = 0.78). The NCD genotype compartment consisted of an excess of genotypes that lacked the 6-repeat (divergent genotypes) (Mid-P exact = 0.004). A number of those genotypes were not detected in the control group (Mid-P exact = 0.007). The RASGEF1C (GGC)-repeat expanded beyond 2-repeats specifically in primates, and was at maximum length in human. We conclude that there is natural selection for the 6-repeat allele of the RASGEF1C (GGC)-repeat in human, and significant divergence from that allele in late-onset NCDs. STR alleles that are predominantly abundant and genotypes that deviate from those alleles are underappreciated features, which may have deep evolutionary and pathological consequences.

Identifiants

pubmed: 34584172
doi: 10.1038/s41598-021-98725-y
pii: 10.1038/s41598-021-98725-y
pmc: PMC8479062
doi:

Substances chimiques

RASGEF1C protein, human 0
ras Guanine Nucleotide Exchange Factors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

19235

Informations de copyright

© 2021. The Author(s).

Références

Neurobiol Aging. 2020 May;89:142.e1-142.e7
pubmed: 32081467
Ageing Res Rev. 2020 Dec;64:101173
pubmed: 32961338
Alzheimers Dement. 2019 Jan;15(1):65-75
pubmed: 30240575
Expert Rev Neurother. 2011 Nov;11(11):1579-91
pubmed: 22014137
PLoS One. 2010 Apr 02;5(4):e10022
pubmed: 20368805
Proc Biol Sci. 2017 Dec 20;284(1869):
pubmed: 29237850
Genetics. 2017 Oct;207(2):697-710
pubmed: 28811387
Clin Epigenetics. 2020 Oct 17;12(1):149
pubmed: 33069246
Sci Rep. 2021 Apr 14;11(1):8163
pubmed: 33854084
JAMA Neurol. 2021 Jul 1;78(7):853-863
pubmed: 34047774
Neurobiol Aging. 2020 Mar;87:139.e1-139.e7
pubmed: 31810584
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Gene. 2015 Sep 10;569(1):88-94
pubmed: 26022613
Neuron. 2021 Jun 2;109(11):1825-1835.e5
pubmed: 33887199
Am J Hum Genet. 2019 Jan 3;104(1):35-44
pubmed: 30554721
Am J Primatol. 2014 Aug;76(8):747-56
pubmed: 24573656
Nat Rev Genet. 2018 May;19(5):286-298
pubmed: 29398703
Public Health Rep. 2009 May-Jun;124(3):471-4
pubmed: 19445426
Neurobiol Dis. 2021 Feb;149:105225
pubmed: 33347974
Gene. 2016 Aug 1;587(1):83-90
pubmed: 27108803
Sci Rep. 2020 Nov 10;10(1):19454
pubmed: 33173136
Hum Mol Genet. 1992 Sep;1(6):397-400
pubmed: 1301913
J Mol Neurosci. 2013 Oct;51(2):389-93
pubmed: 23640536
J Neural Transm (Vienna). 2006 Oct;113(10):1373-82
pubmed: 16604303
JAMA Neurol. 2020 Dec 1;77(12):1559-1563
pubmed: 32852534
Gerontology. 2020;66(5):514-522
pubmed: 32877896
Psychogeriatrics. 2017 Nov;17(6):460-465
pubmed: 28589659
Age Ageing. 1972 Nov;1(4):233-8
pubmed: 4669880
Genet Test Mol Biomarkers. 2017 Aug;21(8):485-490
pubmed: 28723299
Genome Res. 2015 Nov;25(11):1591-9
pubmed: 26290536
Genome Biol. 2006;7 Suppl 1:S12.1-14
pubmed: 16925834
Proc Natl Acad Sci U S A. 2019 Nov 12;116(46):23243-23253
pubmed: 31659027
Acad Emerg Med. 2019 Feb;26(2):226-245
pubmed: 30222232
Nat Genet. 2019 Aug;51(8):1215-1221
pubmed: 31332381
Am J Hum Genet. 2012 Apr 6;90(4):720-6
pubmed: 22482808
Sci Rep. 2021 Jan 28;11(1):2515
pubmed: 33510257

Auteurs

Z Jafarian (Z)

Iranian Research Center on Aging, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.

S Khamse (S)

Iranian Research Center on Aging, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.

H Afshar (H)

Iranian Research Center on Aging, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran. drhoseinafshar@yahoo.com.

H R Khorram Khorshid (HRK)

Personalized Medicine and Genometabolomics Research Center, Hope Generation Foundation, Tehran, Iran.

A Delbari (A)

Iranian Research Center on Aging, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.

M Ohadi (M)

Iranian Research Center on Aging, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran. mi.ohadi@uswr.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH